Panel for Whole Exome Sequencing TWES uses NGS sequencing technology to identify disorders that have mutations in full protein-coding regions or exomes, which equate to more than 19000 genes in the human genome. More than 95% of the exomes are covered by WES, which also contains numerous disease-causing SNPs across the genome and 85% of the disease-causing mutations in Mendelian illnesses. At Genes2Me, the Whole Exome Sequencing (WES) is a comprehensive panel that covers the target region for the entire WES panel. This allows a highly cost-effective sequencing all across the exon region. Call Now for Booking at 08800821778 | social@genes2me.com